Category: Opinion
15 Best Cannabis Investments for 2022
2021 was a brutal year for cannabis stocks. The $1+ billion cannabis ETF MSOS ended…
Agrify vs. urban-gro: which is the better stock?
Ancillary cannabis companies (those that are not plant touching businesses) offer investors a chance to…
Finding value in cannabis growth stocks by using a Price-Sales-Growth (PSG) score
A company’s revenue alone doesn’t help you evaluate a company’s stock value or potential. Growth…
How Parallel’s warrants could earn you over 700%
Warrants are a great way to earn some serious leverage on your favorite stocks. Trulieve’s…
Proof that Canadian LPs are wealth destroyers and American MSOs are wealth creators
If you say anything negative about any of the Canadian cannabis licensed producers (LPs), you’ll…
Study shows Marijuana legalization a federal level would lead to healthier employees, drop in workers’ compensation claims, and fewer opioid-related overdose deaths
New research by the National Bureau of Economic Research suggests that the legalization of marijuana…
Finding the next Jushi (549% 12-month return) – Part 3: Hollister Biosciences
In Part 1, with the help of my Cannabis Investor Portal, I narrowed 29 cannabis…
The 5 best small publicly traded cannabis companies and who is likely to buy them
2020 ended the year with a bunch of mergers and acquisitions in the cannabis space…
The Ayr deal is a good one – pay no attention to the disgruntled Liberty Health Science “no” voters
On Dec 12, 2020, Liberty Health Science announced that they were being acquired in a…
Recent Comments